Akosua’s experience involves working with life science companies on a wide range of FDA-related issues. Her practice focuses on product development and approval, clinical trials, and risk management, in addition to strategic FDA regulatory and compliance advice. Akosua’s advice in this area encompasses pharmacovigilance, Current Good Manufacturing Practice (cGMP), Good Clinical Practice (GCP), advertising and promotion, and Risk Evaluation and Mitigation Strategies (REMS).
Akosua has regularly provided strategic product development and FDA regulatory pathway advice to pharmaceutical manufacturers developing cell, tissue, and gene therapies, as well as other novel products. She also counsels device manufacturers and companies with digital health platforms.
During law school, Akosua was a legal intern at the U.S. Department of Health and Human Services in the Office of the National Coordinator for Health Information Technology and an intern in the Research and Development Law Department of Bristol-Myers Squibb. She also served as a Kahan Health & FDA Law Fellow, which included mentoring law students interested in health and FDA law and helping develop the law school’s health law initiative. Akosua also won first place in the 2021 University of Maryland’s Health Law & Regulatory Compliance Competition, during which she highlighted her passion for helping clients navigate a complex regulatory landscape. Additionally, she received The George Washington University Law School Dean’s Pro Bono Recognition for her work as a Whitman-Walker Legal Volunteer for immigration and asylum matters.
